By David Bautz, PhD NASDAQ: CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Planning for Phase 3 Registration Trial ...

Novel agent abelacimab has potential to be a safer anticoagulant, according to the randomized AZALEA-TIMI 71 trial. The trial had been stopped early because of a surprisingly large reduction in bleeds ...

Newer oral blood thinners were linked to lower nonmajor bleeding risk than warfarin in adults with sickle cell disease, a ...

Atrial fibrillation, or AFib, is a type of irregular heart rhythm that causes your heart to pump less effectively than it should. You’ll get treatment to try to bring back a normal rhythm. Another ...

Purpose: The current indications, dosing, and practical considerations for use of newer anticoagulants in patients with various degrees of renal impairment who do not require dialysis are reviewed.

If you’re experiencing severe side effects from the blood thinner warfarin, a doctor may recommend an alternative known as non-vitamin K oral anticoagulants (NOACs). Non-vitamin K oral anticoagulants ...

Anticoagulants are one of the most commonly prescribed medication classes, and the utilization of these agents is on the rise. Anticoagulants are prescribed for many indications, including prevention ...

Factor Xa inhibitors are a type of anticoagulant, or blood thinner. They’re a short- and long-term therapy for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary ...

Please provide your email address to receive an email when new articles are posted on . Among young patients with provoked venous thromboembolism, shorter duration of anticoagulation is noninferior to ...

Anticoagulant therapy for ischaemic stroke aims to prevent recurrent ischaemic stroke and venous thromboembolism. Several large clinical trials have provided insight into the safety and efficacy of ...

Symmetric peripheral gangrene is an infrequent but devastating complication of critical illness. This condition results in distal tissue losses that typically involve the lower limbs, but in one third ...